The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Imatinib efficacy by tumor genotype in Asian patients with metastatic or recurrent gastrointestinal stromal tumors (GISTs): A retrospective study of Korean GIST Study Group (KGSG).
H. J. Kang
No relevant relationships to disclose
M. Ryu
No relevant relationships to disclose
K. Kim
No relevant relationships to disclose
Y. S. Park
No relevant relationships to disclose
W. H. Kim
No relevant relationships to disclose
S. Im
No relevant relationships to disclose
S. H. Park
No relevant relationships to disclose
K. H. Lee
No relevant relationships to disclose
H. Song
No relevant relationships to disclose
Y. Kang
Consultant or Advisory Role - Novartis
Honoraria - Novartis